SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-20-013253
Filing Date
2020-03-26
Accepted
2020-03-26 17:10:07
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 mgen-s3.htm S-3 1362431
2 EX-4.3 mgen-ex43_6.htm EX-4.3 449327
3 EX-4.5 mgen-ex45_7.htm EX-4.5 143441
4 EX-5.1 mgen-ex51_34.htm EX-5.1 60074
5 EX-23.1 mgen-ex231_35.htm EX-23.1 2606
6 GRAPHIC gzgecgzs2yfv000004.jpg GRAPHIC 2853
7 GRAPHIC gzgecgzs2yfv000007.jpg GRAPHIC 2853
8 GRAPHIC gzgecgzs2yfv000003.jpg GRAPHIC 2853
9 GRAPHIC gzgecgzs2yfv000001.jpg GRAPHIC 2853
10 GRAPHIC g2e22qgl3lt5000001.jpg GRAPHIC 28720
11 GRAPHIC gzgecgzs2yfv000005.jpg GRAPHIC 2853
12 GRAPHIC gzgecgzs2yfv000002.jpg GRAPHIC 2853
13 GRAPHIC gzgecgzs2yfv000006.jpg GRAPHIC 2853
  Complete submission text file 0001564590-20-013253.txt   2087416
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237413 | Film No.: 20746894
SIC: 8071 Services-Medical Laboratories